
DarioHealth (DRIO) Stock Forecast & Price Target
DarioHealth (DRIO) Analyst Ratings
Bulls say
DarioHealth is a virtual chronic care company with a unique business model that combines hardware, software, and personalized coaching to drive behavior change and improve patient outcomes. The recent acquisition of Twill and transition to the enterprise market positions DarioHealth for success, with potential for revenue growth, increased EBITDA, and positive cash flow by mid 2027. However, risks in the HCIT space, such as government program cuts and price competition, could impact spending and customer retention. Overall, DarioHealth's strong value proposition and potential for growth make it a promising investment opportunity.
Bears say
DarioHealth is experiencing a challenging demand environment, potentially due to the company's focus on cost management. While the company has made improvements in its cost management and has a strong pipeline, there is limited visibility for growth in its B2B2C and strategic partnerships channels. There is also risk of churn and capturing sufficient lives. However, there is potential for upside if the company can cross-sell its products and services to legacy Twill customers and reach breakeven sooner than expected through lower OpEx.
This aggregate rating is based on analysts' research of DarioHealth and is not a guaranteed prediction by Public.com or investment advice.
DarioHealth (DRIO) Analyst Forecast & Price Prediction
Start investing in DarioHealth (DRIO)
Order type
Buy in
Order amount
Est. shares
0 shares